由SHORT综合征引起的非典型糖尿病:一个病例报告
Aili Wang1,2, Miao Xu1, Li Li1
1Department of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
Frontiers in endocrinology
|December 30, 2024
概括
SHORT综合征是一种罕见的遗传疾病,可导致严重的胰岛素抵抗. 一个案例研究表明,生活方式的改变和像甲福明这样的药物改善了患有这种疾病的患者的葡萄糖控制和胰岛素敏感性.
科学领域:
- 遗传学 是一个遗传学.
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 肖特综合征是一种罕见的自体主导遗传疾病.
- 它主要是由PIK3R1基因中的功能丧失变异引起的.
- 患者可能会出现各种症状,包括身高矮和延迟牙喷发.
研究的目的:
- 报告一个患有SHORT综合征的成年女性异常葡萄糖代谢和严重胰岛素抵抗病例.
- 描述该患者胰岛素抵抗综合治疗计划的管理和结果.
- 为 SHORT 综合征患者提供未来治疗策略的见解.
主要方法:
- 一个被诊断患有SHORT综合征的中国成年女性的案例报告.
- 基因分析发现了一个PIK3R1基因变异 (c.1945C>T).
- 一个治疗计划,包括生活方式干预,甲福林,和voglibose被实施用于血糖控制和胰岛素抵抗.
主要成果:
- 该患者在9年内表现出异常的葡萄糖代谢和严重的食后胰岛素抵抗.
- 经过6个月的治疗,血糖水平显著改善.
- 在综合管理计划后,胰岛素耐药性显著改善.
结论:
- 这一案例凸显了SHORT综合征患者显著胰岛素抵抗的潜力.
- 多模式治疗方法,包括改变生活方式和药物治疗,可以有效地管理葡萄糖代谢和胰岛素抵抗.
- 需要进行进一步的研究,以确定SHORT综合征中胰岛素抵抗的最终治疗指南.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Pathophysiology of Diabetes
780
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
780
Diabetes: Symptoms, Diagnosis, and Complications
466
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
466
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Insulin: Dosing Regimen and Adverse Effects
121
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
121
Hypoglycemia and Glucagon
131
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
131


